[Beta 2 microglobulin in children with neuroinfections]

Area of Science:

• Neuroscience
• Immunology
• Infectious Diseases

Background:

• Beta2 microglobulin (B2M) is a protein found on cell surfaces.
• Elevated B2M levels can indicate inflammation or cell turnover.
• Meningitis, an inflammation of the membranes surrounding the brain and spinal cord, requires accurate diagnosis.

Purpose of the Study:

• To investigate cerebrospinal fluid (CSF) and plasma B2M concentrations in children with bacterial and viral meningitis.
• To assess the diagnostic utility of B2M levels in differentiating meningitis types.
• To explore the potential for intrathecal B2M production during central nervous system infections.

Main Methods:

• Enzyme linked fluorescent assay (ELFA) used for B2M quantification.
• Study included children diagnosed with bacterial meningitis, viral meningitis (mumps, enteroviral), and healthy controls.
• CSF and plasma samples collected at various disease stages: admission, during treatment, and at recovery.

Main Results:

• Significantly higher CSF B2M levels observed in bacterial and viral meningitis patients compared to controls.
• CSF B2M levels at 24-48 hours of treatment in bacterial meningitis were higher than at the onset of viral meningitis.
• Elevated plasma B2M noted only in enteroviral meningitis; positive correlation between CSF B2M and inflammatory markers (CRP, ERS) found.

Conclusions:

• CSF B2M is a potential biomarker for diagnosing meningitis in children.
• CSF B2M levels may assist in differentiating bacterial from viral meningitis, especially in challenging diagnostic scenarios.
• Elevated CSF B2M relative to plasma B2M suggests intrathecal production during CNS infections.